ORIFARM GROUP A/S — Credit Rating and Financial Key Figures

ORIFARM GROUP A/S (CVR number: 27347282) is a company from ODENSE. The company recorded a gross profit of 1478 kEUR in 2025, demonstrating a decline of -26 % compared to the previous year. The operating profit was -30.1 mEUR, while net earnings were 51.8 mEUR. The profitability of the company measured by Return on Assets (ROA) was 7.8 %, which can be considered decent but Return on Equity (ROE) was 13.1 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 41.5 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. ORIFARM GROUP A/S's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.